Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 27c, beats revenue

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q2 EPS of $0.18, $0.27 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $12 million versus the consensus estimate of $6.5 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Eton Pharmaceuticals (ETON) PT Raised to $65 at H.C. Wainwright
• Southland Holdings (SLND) Misses Q2 EPS by 122c
• SeaStar Medical (ICU) Misses Q1 EPS by 4c